You have 9 free searches left this month | for more free features.

lenalidomide

Showing 1 - 25 of 662

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma (MZL)
  • Chiang Mai, Thailand
    Chiang Mai University
Nov 20, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Lenalidomide
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2023

Advanced HCC Trial (Lenalidomide)

Not yet recruiting
  • Advanced HCC
  • Lenalidomide
  • (no location specified)
Apr 16, 2023

Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

Not yet recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +2 more
  • Augusta, Georgia
    Georgia Cancer Center at Augusta University
Apr 26, 2023

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Epcoritamab
  • Lenalidomide
  • (no location specified)
Jan 20, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Jan 9, 2023

Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

Not yet recruiting
  • Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2023

Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

Terminated
  • Multiple Myeloma
  • lenalidomide
  • +3 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023

Relapsed/Refractory Marginal Zone Lymphoma Trial in China (Orelabrutinib, Lenalidomide, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Marginal Zone Lymphoma
  • Guangzhou, Guangdong, China
  • +10 more
Oct 8, 2023

Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Cologne, Germany
    University of Cologne
Oct 14, 2022

Follicular Lymphoma Trial in Shanghai (lenalidomide, rituximab, parsaclisib)

Not yet recruiting
  • Follicular Lymphoma
  • lenalidomide
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin hospital, school of medicine, Shanghai jiao tong universi
May 10, 2023

Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

Completed
  • Lymphoid Leukemia
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Jan 30, 2023

Primary CNS Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Methotrexate)

Completed
  • Primary Central Nervous System Lymphoma
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 18, 2022

Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

DLBCL Trial in San Juan (PF-07901801, Tafasitamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • San Juan, Puerto Rico
    Auxilio Mutuo Cancer Center
Jan 19, 2023

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 29, 2022

Multiple Myeloma Trial in Nantong (Colchicine, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Mar 25, 2023

Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

Completed
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Laboratory Biomarker Analysis
  • Lenalidomide
  • Houston, Texas
    M D Anderson Cancer Center
Oct 18, 2022

Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

Not yet recruiting
  • Follicular Lymphoma
  • Biospecimen Collection
  • +7 more
  • Duarte, California
  • +1 more
Oct 27, 2023

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Duarte, California
  • +9 more
Jan 11, 2023

Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

Recruiting
  • Cutaneous T-Cell Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023